rvm-v002
Vaccineexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 22, 2023 (NCT05788185)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
immunity, active - sars-cov-2
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05788185 | Phase 1/Phase 2 (Phase 2) | Mar 22, 2023 | RVAC Medicines (US), Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| RVAC Medicines (US), Inc. | For profit | 1 | 1 | 1 | 2023 |
1 organizations
Page 1 / 1